Gaston J H Franssen

Long-Term Efficacy, Survival, and Safety of [177Lu-DOTA0,Tyr3]octreotate in Patients with Gastroenteropancreatic and Bronchial Neuroendocrine Tumors

Tessa Brabander, Wouter A. van der Zwan, Jaap J.M. Teunissen et al. · Clinical Cancer Research · 2017 · 580 citations

Subacute haematotoxicity after PRRT with 177Lu-DOTA-octreotate: prognostic factors, incidence and course

Hendrik Bergsma, Mark Konijnenberg, Boen L.R. Kam et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 173 citations · Full text

Prevalence and clinical features of the ectopic ACTH syndrome in patients with gastroenteropancreatic and thoracic neuroendocrine tumors

Kimberly Kamp, R A Alwani, Esther Korpershoek et al. · European Journal of Endocrinology · 2015 · 102 citations · Full text

Treatment of inoperable or metastatic paragangliomas and pheochromocytomas with peptide receptor radionuclide therapy using 177Lu-DOTATATE

Wouter T. Zandee, Richard A. Feelders, Daan A. Smit Duijzentkunst et al. · European Journal of Endocrinology · 2019 · 76 citations · Full text

Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study

Sara G Creemers, Richard A. Feelders, Frank H. de Jong et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 63 citations · Full text